Psychiatry & Neurology, Clinical Neurophysiology · Norman, OK
NPI
1922200435
Since 2007
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
2821 36th Ave NW Ste 200
Norman, OK, 73072
Phone (405) 307-5700
Groups this clinician bills Medicare through
Medicare paid, 2024
$221K
8,994 services
Medicare patients, 2024
974
Average age 72
Drug cost, 2024
$1.4M
5,314 prescriptions
Company payments, 2025
$4,646
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Geetha B Kandimala was code 99214 (office e&m - established), 896 times for 582 patients. In total Geetha B Kandimala billed 8,994 services in 44 codes, and Medicare paid $221K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 896 | 582 | $80.45 | $72K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 404 | 313 | $11.52 | $4,654 |
| 95886 Electrical Nerve Conductivity | Office | 277 | 147 | $68.81 | $19K |
| 99204 Office E&M - New | Office | 137 | 137 | $104.71 | $14K |
| 99213 Office E&M - Established | Office | 115 | 101 | $52.47 | $6,034 |
| 99483 Office/Outpatient Services | Office | 89 | 89 | $184.51 | $16K |
| 99215 Office E&M - Established | Office | 66 | 63 | $125.68 | $8,295 |
| 95912 Electrical Nerve Conductivity | Office | 64 | 64 | $163.85 | $10K |
| 95913 Electrical Nerve Conductivity | Office | 42 | 42 | $201.60 | $8,467 |
| 11105 Skin Biopsy | Office | 32 | 16 | $44.06 | $1,410 |
| 95810 Sleep Study | Office | 24 | 24 | $82.53 | $1,981 |
| 95909 Electrical Nerve Conductivity | Office | 21 | 21 | $70.62 | $1,483 |
| 99223 Hospital E&M - Initial | Facility | 20 | 20 | $124.97 | $2,499 |
| 95811 Sleep Study | Office | 20 | 19 | $196.93 | $3,939 |
| 11104 Skin Biopsy | Office | 16 | 16 | $92.27 | $1,476 |
By year: 2022 $246K for 7,294 services; 2023 $252K for 8,676 services; 2024 $221K for 8,994 services.
Medicare prescription drug claims, 2024
In 2024, the drug Geetha B Kandimala prescribed most often to Medicare patients was Gabapentin, with 413 prescriptions and refills. In total Geetha B Kandimala wrote 5,314 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 413 | 959 | 144 | $9,507 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 410 | 814 | 123 | $15K |
| Topiramate Generic | 336 | 641 | 80 | $3,790 |
| Memantine Hcl Generic | 262 | 647 | 88 | $6,857 |
| Donepezil Hcl Generic | 262 | 645 | 90 | $2,860 |
| Levetiracetam Generic | 218 | 445 | 52 | $12K |
| Rizatriptan Rizatriptan Benzoate | 213 | 223 | 72 | $5,994 |
| Lacosamide Generic | 185 | 319 | 35 | $28K |
| Lamotrigine Generic | 181 | 263 | 26 | $2,865 |
| Ropinirole Hcl Generic | 162 | 339 | 45 | $5,009 |
| Quetiapine Fumarate Generic | 140 | 271 | 38 | $1,850 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 121 | 273 | 36 | $6,660 |
| Cyclobenzaprine Hcl Generic | 108 | 157 | 44 | $1,690 |
| Pregabalin Generic | 99 | 196 | 26 | $3,898 |
| Sertraline Hcl Generic | 88 | 177 | 22 | $1,276 |
Brand drugs: 519 claims; generic drugs: 4,795 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Geetha B Kandimala $4,646 ($4,646 in general payments such as food, travel and fees) from 26 companies. The largest payer was Abbvie Inc. with $986.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.